your market intelligence analyst
Search Results
15 results
Your search is now limited to «Excipients» expert search.
Policy & Medicine 12/05/2019 05:05
Last week, the US Food and Drug Administration (“FDA”) released a draft guidance which provides recommendations regarding the need for comparative clinical immunogenicity studies to support biosimilar insulin applications. The draft, entitled Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products, is intended to “facilitate the development of, and improve patient access to, life-saving insulin […]
PR Newswire 12/02/2019 20:00
TOKYO, Dec. 2, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the presentation of new data in acute myeloid leukemia (AML) at the 61st American Society of Hematology (ASH) Annual Meeting, taking place Dec. 7-10...

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.